Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 377-382

  Den Hollander, Jan G ^a,c   Knudsen, Jenny D ^b   Mouton, Johan W ^a   Fuursted, Kurt ^b   Frimodt Møller, Niels ^b   Verbrugh, Henri A ^a   Espersen, Frank ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b STATENS SERUM INSTITUT   (Denmark)

^c Zuiderziekenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DISEASE MODELS, ANIMAL; ERYTHROMYCIN; FEMALE; MICE; PERITONITIS; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031893544     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Azoulay-Dupuis, E., E. Vallée, J. P. Bedos, M. Muffat-Joly, and J. J. Pocidalo. 1991. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. Antimicrob. Agents Chemother. 35:1024-1028.
2. Blaser, J., P. Vergères, A. F. Widmer, and W. Zimmerli. 1995. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob. Agents Chemother. 39:1134-1139.
3. Butler, T., and A. E. Girard. 1993. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. J. Antimicrob. Chemother. 31:313-319.
4. Chapin-Robertson, K., and S. C. Edberg. 1986. Measurement of antibiotics in human body fluids: techniques and significance, p. 295-366. In V. Lorian (ed.), Antibiotics in laboratory medicine - 1986, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
5. Daniel, R. R. 1993. Comparison of azithromycin and co-amoxiclav in treatment of otitis media in children. J. Antimicrob. Chemother. 31(Suppl. E): 65-71.
6. Davila, D., L. Kolacny-Babic, and F. Plavšic. 1991. Pharmacokinetics of azithromycin after single oral dosing of experimental animals. Biopharm. Drug Dispos. 12:505-514.
7. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
8. Frimodt-Møller, N., M. W. Bentzon, and V. F. Thomsen. 1983. The pneumococcus and mouse protection test: importance of the lag-phase in vivo. Chemotherapy 29:128-134.
9. Girard, A. E., C. R. Cimochowski, and J. A. Faiella. 1993. The comparative activity of azithromycin, macrolides and amoxicillin against streptococci in experimental infections. J. Antimicrob. Chemother. 31(Suppl. E):29-37.
10. Girard, A. E., D. Girard, A. R. English, T. D. Gootz, C. R. Cimochowski, J. A. Faiella, et al. 1987. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents Chemother. 31:1948-1954.
11. Girard, D., J. M. Bergeron, W. B. Milisen, and J. A. Retsema. 1993. Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses. J. Antimicrob. Chemother. 31(Suppl. E):17-28.
12. Graphpad Software Inc. 1995. Prism users guide. Graphpad Software Inc., San Diego, Calif.
13. Graphpad Software Inc. 1990. Instat 2 program manual. Graphpad Software Inc., San Diego, Calif.
14. Hamill, J. 1993. Multicentre comparison of azithromycin and penicillin V in treatment of acute streptococcal pharyngitis and tonsillitis in children. J. Antimicrob. Chemother. 31(Suppl. E):89-94.
15. Hoepelman, A. I. M., A. P. Sips, J. L. M. van Helmond, P. W. C. van Barneveld, A. J. Neve, M. Zwinkels, M. Rozenberg-Arska, and J. Verhoef. 1993. A single-blind comparison of a three-day azithromycin and ten-day co-amoxiclav treatment of acute and lower respiratory tract infections. J. Antimicrob. Chemother. 31(Suppl. E):147-152.
16. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
17. Knudsen, J. D., N. Frimodt-Møller, and F. Espersen. 1995. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob. Agents Chemother. 39:1253-1258.
18. Lode, H., K. Borner, P. Koeppe, and T. Schaberg. 1996. Azithromycin - review of key chemical, pharmacokinetic and microbiological features. J. Antimicrob. Chemother. 37(Suppl. C):1-8.
19. Lund, E., and J. Henrichsen. 1978. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods Microbiol. 12:241-262.
20. Mouton, J. W., and J. G. den Hollander. 1994. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 38:931-936.
21. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Nilsen, O. G. 1987. Comparative pharmacokinetics of macrolides. J. Antimicrob. Chemother. 20(Suppl. B):81-88.
23. Retsema, J. A., J. M. Bergeron, D. Girard, W. B. Milisen, and A. E. Girard. 1993. Preferential concentration of azithromycin in an infected mouse thigh model. J. Antimicrob. Chemother. 31(Suppl. E):5-16.
24. Retsema, J. A., A. E. Girard, D. Girard, and W. B. Milisen. 1990. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J. Antimicrob. Chemother. 25(Suppl. A):83-89.
25. Ritschel, W. A. 1982. Compartment models, p. 199-218. In Handbook of basic pharmacokinetics, 2nd ed. Drug Intelligence Publications Inc., Hamilton, Ill.
26. Rodriguez-Solares, A., F. Perez-Gutierrez, J. Prosperi, E. Milgram, and A. Martin. 1993. A comparative study of efficacy, safety, and tolerance of azithromycin, dicloxacillin, and flucloxacillin in treatment of children with acute skin and skin-structure infections. J. Antimicrob. Chemother. 31(Suppl. E):103-109.
27. SAS Institute Inc. 1990. SAS users guide. SAS Institute Inc., Cary, N.C.
28. Shepard, R. M., and F. C. Faulkner. 1990. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother. 25(Suppl. A):49-60.
29. Veber, B., E. Vallée, J. M. Desmonts, J. J. Pocidalo, and E. Azoulay-Dupuis. 1993. Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia. J. Antimicrob. Chemother. 32:473-482.
30. Whitman, M. S., and A. R. Tunkel. 1992. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect. Control Hosp. Epidemiol. 13:357-368.